# A Long-term Study of the Safety of MK-0954A in Patients With Essential Hypertension (MK-0954A-351)

> **NCT01307033** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 278 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** MK-0954A
- **DRUG:** MK-954H
- **DRUG:** Placebo to MK-0954A
- **DRUG:** Placebo to MK-954H

## Key facts

- **NCT ID:** NCT01307033
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03-29
- **Primary completion:** 2012-12-04
- **Final completion:** 2012-12-04
- **Target enrollment:** 278 (ACTUAL)
- **Last updated:** 2024-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01307033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01307033, "A Long-term Study of the Safety of MK-0954A in Patients With Essential Hypertension (MK-0954A-351)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01307033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*